Across TCGA pan-cancer cohorts, OR14A16 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of OR14A16’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where OR14A16 RNA is repressed in tumor relative to normal tissue. In most cancer types OR14A16 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

THCA and BRCA are the cancer types where OR14A16 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR14A16 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	All	−0.207	<.001	9	view →
BRCA	All	All	+0.068	.045	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: OR14A16 RNA expression & survival · all OR14A16 data types